Company profile for Icon Bioscience Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. The Company has developed 3 FDA-approved sustained-release treatments in ophthalmology. In addition, DEXYCU (dexamethasone intraocular suspension) 9...
EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. The Company has developed 3 FDA-approved sustained-release treatments in ophthalmology. In addition, DEXYCU (dexamethasone intraocular suspension) 9% was approved by U.S. Food and Drug Administration (FDA) on February 9, 2018. ILUVIEN

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
480 Pleasant Street\nSuite B300\nWatertown MA 02472\n
Telephone
Telephone
(617) 926-5000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Icon to buy contract researcher PRA Health for $12B
Icon to buy contract researcher PRA Health for $12B

26 Feb 2021

// K. Jensen BIOPHARMADIVE

https://www.biopharmadive.com/news/icon-pra-health-acquistion-contract-research-cro/595641/

K. Jensen BIOPHARMADIVE
26 Feb 2021

https://www.businesswire.com/news/home/20210224005484/en

BUSINESSWIRE
24 Feb 2021

https://www.businesswire.com/news/home/20201007005398/en

BUSINESSWIRE
07 Oct 2020

https://www.businesswire.com/news/home/20201007005398/en

BUSINESSWIRE
06 Oct 2020

https://www.businesswire.com/news/home/20200903005029/en

BUSINESSWIRE
02 Sep 2020
Icon nabs former Optum, FDA and AstraZeneca exec as CMO
Icon nabs former Optum, FDA and AstraZeneca exec as CMO

06 May 2020

// Ben Adams FIERCE BIOTECH

https://www.fiercebiotech.com/cro/icon-nabs-optum-insights-fda-and-astrazeneca-exec-as-new-chief-medical-officer

Ben Adams FIERCE BIOTECH
06 May 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty